The three properties that decide pressability

• Compressibility: can the powder form a coherent bond under load? Driven by particle deformation and bonding area.

• Flowability: does it feed uniformly into the die? Poor flow = weight variation, regardless of press quality.

• Lubrication: does it release from the punch without sticking? Usually a magnesium stearate step within a defined range.

How to measure them

• Compressibility: Heckel plot (ln(1/porosity) vs pressure) or Kawakita equation; slope reveals plastic vs brittle behaviour.

• Flow: angle of repose (<30° good), Carr index (<15% free-flowing) and Hausner ratio (<1.2 ideal).

• Lubrication: ejection force and sticking incidence during a small press trial.

Measured powder data

API vs excipient roles

The diluent (MCC, lactose) carries compressibility; the binder builds the bond; the disintegrant controls breakdown; the lubricant (0.25–1% magnesium stearate) prevents sticking. Too much lubricant actually weakens the tablet — a classic over-lubrication failure I see in the Gulf where humidity pushes formulators to add "just a bit more."

When granulation is mandatory

• Compressibility too low for the target hardness.

• Flow (Carr >20%) too poor for uniform die fill at speed.

• Low-dose (<1%) API needing content uniformity — granulation binds it evenly.

How powder properties dictate press settings

A free-flowing, compressible blend runs at high rpm with modest force and light pre-compression. A poorly flowing blend needs a servo force feeder, lower rpm and careful pre-compression to keep RSD under 2%. The press settings are a response to the powder, never the other way around.

Compliance and specification

Powder specs sit inside the EU GMP and FDA 21 CFR 211 framework; the validated range (PAR) for lubricant level, moisture and blend uniformity must be documented under ISO 9001, with ISO 13485 for device-linked products. Auditors want the Heckel/Kawakita data and the blend-uniformity study, not just the tablet.

Real cases (anonymized)

• Southeast Asia generic: API+DCP blend with Carr 23% capped at speed; wet granulation dropped Carr to 14% and enabled 80 rpm pressing.

• EU low-dose CDMO: 0.5 mg active, granulated then blended; content uniformity passed, RSD 1.8%.

• Middle East plant: over-lubrication (1.8% stearate) weakened tablets; retuning to 0.7% restored hardness without sticking.

Pain points

• Specifying the press before the powder is characterised.

• Over-lubrication weakening tablets in humid plants.

• Content-uniformity failure on low-dose without granulation.

Misconceptions

• "A stronger press fixes weak powder." It cannot add bonding the material lacks.

• "More lubricant is safer." Past ~1% it weakens the tablet.

• "Flow doesn't matter at low speed." It drives weight RSD at every speed.

Direct compression vs granulation

Procurement pitfalls

• Ordering a press without sending powder characterisation data to the supplier.

• No blend-uniformity and lubricant-range study in the dossier.

• Assuming the same press settings work across different API blends.

FAQ

What powder property matters most?

Compressibility for hardness, flow for weight uniformity — both must be measured, not assumed.

How do I know if I need granulation?

If Carr index >20% or the API is low-dose (<1%), granulate before pressing.

Can too much lubricant hurt?

Yes — above ~1% magnesium stearate it weakens the tablet bond.

What is a Heckel plot for?

It reveals whether a powder deforms plastically or fractures, guiding force selection.

Does humidity affect powder pressing?

Strongly — it drives sticking and tempts over-lubrication; control the feed environment.

Should I send powder data to the press maker?

Always — it determines feeder type, force range and pre-compression need.

What compliance covers powder specs?

EU GMP / FDA 21 CFR 211 with ISO 9001; ISO 13485 for device-linked products.

Can poor-flow powder ever run on a press?

Only with a force feeder and slower speed; granulation is the robust fix.